MINK THERAPEUTICS INC
(NASDAQ: INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
0.869
-0.020
(-2.25%)
Range
- - -
(-%)
Open
-
Previous Close
0.889
Bid Price
1.960
Bid Volume
8
Ask Price
1.970
Ask Volume
8
Volume
24,863
Value
-
Remark
Delayed prices. Updated at 25 Apr 2024 23:43.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
